Sentence examples for potentially expediting from inspiring English sources

For example, Dowsett et al. found that changes in Ki-67 in the neoadjuvant setting may be used to predict likely benefit (improved disease-free and overall survival) of AIs in the adjuvant setting [ 74], potentially expediting clinical development.

Finally, thiazide diuretics, as compared to thiazide-like diuretics (indapamide), increase uric acid, potentially expediting the development of gout through volume contraction and competition with uric acid for renal tubular secretion.

Much of the design of these siRNAs can be accomplished bioinformatically, thus potentially expediting drug discovery and opening new avenues of therapy for many uncommon, orphan, or emerging diseases.

This may help to both avoid inappropriate treatment in such people and prompt further investigation, potentially expediting medical intervention, in the case of a suspected dissection.

Kidney sonopalpation may potentially expedite ED care, especially in instances failing to reach an acceptable diagnostic threshold when relying on the tools currently in common use.

Chemical tools for selectively targeting the activities of individual PTPs would help to elucidate PTP signaling roles and potentially expedite the validation of PTPs as therapeutic targets.

Strategies for chemically targeting the function of individual PTPs selectively could serve to elucidate the signaling roles of these enzymes and would potentially expedite validation of the therapeutic promise of PTP inhibitors.

This could potentially expedite patient care.

It also supports the results of previous research showing that virtual panels may potentially expedite the elicitation process, minimize burden on participants, allow the conduct of larger and more diverse panels, and include geographically distributed participants [ 8, 9].

This could potentially expedite the journey from basic science discovery to clinical utility, a translation process which to date has had limited success in the applications of 'omics technologies in maternal-fetal newborn health.

We suggest that future trial-wide genetic profiling of patients may potentially expedite identification of markers of idiosyncratic drug reaction to novel oncological agents, including those denoting HLA allele status [ 20], permitting genotype based risk stratification.